Army eyes Weight-Loss drug to boost soldier fitness
NCT ID NCT06468748
Summary
This planned study aimed to see if the weight-loss drug Wegovy (semaglutide) could help control obesity in active-duty military members. It would have measured how the drug affects body fat, muscle mass, and physical performance over 24 weeks of treatment, followed by a year of observation. The goal was to understand if this medication could be a useful tool for improving health and readiness in the military, but the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
USARIEM
Natick, Massachusetts, 01760, United States
Conditions
Explore the condition pages connected to this study.